Skip to content
Menu

OnKure Therapeutics, Inc. OKUR

Full chart Compare
Set alert

Price alert · OKUR

All alert types
2.63 USD -0.38 (-12.62%)

Regular-session close

2.63 0.00 0.00%

After hours · Nov 13, 4:00 PM ET

2.60 Day range 3.08
2.01 52-week range 5.38
YTD
-9.31%
1 year
-16.24%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 34.75 +1221.3% upside
Target (low)
31.00
Target (mean)
34.75
Target (high)
40.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 3
  • 2 months ago 3

Revenue and earnings: history and forecast

What OKUR reported, and what analysts expect for the next two fiscal years

Earnings per share

Analysts expect earnings per share of -1.08 in the current fiscal year.

Fiscal years. Estimates are the analyst consensus and change as analysts revise them; the percentages are the change on the year before. Earnings per share is on the basis analysts estimate, which can differ from the reported (GAAP) figure.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OKUR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.74-1.10 – -0.380.000.0%00.0%2
Next quarter-1.19-1.19 – -1.190.000.0%00.0%1
Current year-1.08-1.08 – -1.080.000.0%00.0%1
Next year-3.10-4.98 – -1.22-1.08-187.0%666.67K0.0%2

Upgrades and downgrades

The latest rating changes

OKUR analyst upgrades and downgrades
DateFirmActionFromTo
Dec 5, 2024Leerink PartnersInitiated—Outperform
Nov 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 10, 2024OppenheimerInitiated—Outperform

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.